Making Them Commit: Strategies to Influence Phenotypic Differentiation in Mesenchymal Stem Cells.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Surgery

Background:

• Tendon, bone, and cartilage defects cause pain and dysfunction, with limited self-healing capacity.
• Current treatments often result in inferior tissue repair, leading to high re-injury and revision surgery rates.
• Mesenchymal stem cells (MSCs) are explored for tissue regeneration due to their multipotency and accessibility.

Purpose of the Study:

• To review strategies for differentiating mesenchymal stem cells (MSCs) into tenocytes, osteoblasts, and chondrocytes.
• To discuss the potential and limitations of using MSCs for tendon, bone, and cartilage regeneration.
• To examine challenges associated with in vivo and clinical applications of MSC-based therapies.

Main Methods:

• Narrative literature review.
• Analysis of various strategies for MSC differentiation into specific cell lineages (tenocytes, osteoblasts, chondrocytes).
• Discussion of existing research on MSCs in regenerative medicine for musculoskeletal tissues.

Main Results:

• MSCs offer potential for regenerating specialized connective tissues like tendons, bone, and cartilage.
• Various differentiation protocols exist, but achieving fully functional, native-like tissue remains a challenge.
• Significant hurdles remain for the safe and effective clinical translation of MSC-based regenerative strategies.

Conclusions:

• Mesenchymal stem cells (MSCs) hold significant promise for tendon, bone, and cartilage regeneration.
• Further research is needed to optimize MSC differentiation and overcome in vivo and clinical application challenges.
• Successful MSC-based therapies could revolutionize the treatment of complex musculoskeletal injuries and defects.